Zurich Insurance Group AG (ZFIN)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 668.20 |
|---|---|
| 52-week range | 578.40 – 680.00 |
| Return, 1 month / 3 months | +8.4% / −0.3% |
| Return, 1 year / 3 years | +13.2% / – |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 18.2% |
| Worst drawdown (1 year) | -11.5% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zurich Insurance Group is a Swiss insurance company based in Zurich. It provides property and casualty insurance as well as life insurance to individuals, small businesses and large commercial customers. Its personal lines cover motor, home and travel risks, while its commercial business serves companies with liability, property and specialty cover. The group also offers life and pension products and operates in markets across Europe, the Americas, Asia and other regions through local subsidiaries and agents.
On this site Zurich Insurance Group AG appears as a stock on the Deutsche Börse Xetra (Germany), code ZFIN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zurich Insurance Group AG (ZFIN) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 668.20 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 90 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.2% and over the last three months it fell 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.7% | ||
| From 52-week high | -1.1% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.3% | ||
| 6-month return | 13.6% | ||
| 12-month return, skipping the last month | 4.4% | ||
| Stability (higher is calmer) | 96 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.5% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | +8.4% |
| 3 months | −0.3% |
| 6 months | +13.6% |
| 1 year | +13.2% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 633.26 / 614.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Apr 2026 | CHF 32.3820 |
| 5 Apr 2019 | CHF 20.5086 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.